Cargando…

Mineralocorticoid receptor antagonist use in chronic kidney disease with type 2 diabetes: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Association (ERA)

Chronic kidney disease (CKD) in individuals with type 2 diabetes (T2D) represents a major public health issue; it develops in about 30%–40% of patients with diabetes mellitus and is the most common cause of CKD worldwide. Patients with CKD and T2D are at high risk of both developing kidney failure a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sarafidis, Pantelis, Iatridi, Fotini, Ferro, Charles, Alexandrou, Maria-Eleni, Fernandez-Fernandez, Beatriz, Kanbay, Mehmet, Mallamaci, Francesca, Nistor, Ionut, Rossignol, Patrick, Wanner, Christoph, Cozzolino, Mario, Ortiz, Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	CKJ Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616462/ https://www.ncbi.nlm.nih.gov/pubmed/37915899 http://dx.doi.org/10.1093/ckj/sfad139

Ejemplares similares

Atherosclerotic renovascular disease: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Association (ERA) and the Working Group Hypertension and the Kidney of the European Society of Hypertension (ESH)
por: Sarafidis, Pantelis A, et al.
Publicado: (2023)

The future of European Nephrology ‘Guidelines’—a declaration of intent by European Renal Best Practice (ERBP)
por: Vanholder, Raymond, et al.
Publicado: (2009)

SGLT2i for evidence-based cardiorenal protection in diabetic and non-diabetic chronic kidney disease: a comprehensive review by EURECA-m and ERBP working groups of ERA
por: Mark, Patrick B, et al.
Publicado: (2023)

Are endourological procedures for nephrolithiasis treatment associated with renal injury? A review of potential mechanisms and novel diagnostic indexes
por: Mykoniatis, Ioannis, et al.
Publicado: (2020)

What is central to renal nutrition: protein or sodium intake?
por: Wang, Angela Yee-Moon, et al.
Publicado: (2023)

Oncogenic mechanisms in renal insufficiency
por: Volovat, Simona Ruxandra, et al.
Publicado: (2020)

Intravenous iron therapy and the cardiovascular system: risks and benefits
por: Del Vecchio, Lucia, et al.
Publicado: (2020)

Diagnosis, prevention and treatment of haemodialysis catheter-related bloodstream infections (CRBSI): a position statement of European Renal Best Practice (ERBP)
por: Vanholder, Raymond, et al.
Publicado: (2010)

Assessment of hypertension in kidney transplantation by ambulatory blood pressure monitoring: a systematic review and meta-analysis
por: Pisano, Anna, et al.
Publicado: (2021)

A roadmap for optimizing chronic kidney disease patient care and patient-oriented research in the Eastern European nephrology community
por: Sever, Mehmet Şükrü, et al.
Publicado: (2020)

Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association
por: Zoccali, Carmine, et al.
Publicado: (2023)

Early aging and premature vascular aging in chronic kidney disease
por: Tanriover, Cem, et al.
Publicado: (2023)

New and old GFR equations: a European perspective
por: Delanaye, Pierre, et al.
Publicado: (2023)

Management of acute renal replacement therapy in critically ill cirrhotic patients
por: Del Risco-Zevallos, Jimena, et al.
Publicado: (2022)

European Renal Best Practice endorsement of guidelines for diagnosis and therapy of thrombotic thrombocytopaenic purpura published by the International Society on Thrombosis and Haemostasis: A European Renal Best Practice (ERBP) endorsement of ISTH Guidelines for Treatment of Thrombotic Thrombocytopaenic Purpura (TTP) with some refinements for Europe
por: Eller, Kathrin, et al.
Publicado: (2022)

The renal patient seen by non-renal physicians: the kidney embedded in the ‘milieu intérieur’
por: Perez-Villa, Felix, et al.
Publicado: (2020)

A history of uraemic toxicity and of the European Uraemic Toxin Work Group (EUTox)
por: Vanholder, Raymond, et al.
Publicado: (2021)

A brand-new cardiorenal syndrome in the COVID-19 setting
por: Apetrii, Mugurel, et al.
Publicado: (2020)

Impact of public restrictive measures on hypertension during the COVID-19 pandemic: existing evidence and long-term implications
por: Karagiannidis, Artemios G, et al.
Publicado: (2022)

Pharmacokinetic relevance of glomerular hyperfiltration for drug dosing
por: Zoccali, Carmine, et al.
Publicado: (2023)

Sweet dreams: therapeutic insights, targeting imaging and physiologic evidence linking sleep, melatonin and diabetic nephropathy
por: Afsar, Baris, et al.
Publicado: (2020)

Donor obesity and weight gain after transplantation: two still overlooked threats to long-term graft survival
por: Kanbay, Mehmet, et al.
Publicado: (2022)

Kidney transplantation and COVID-19 renal and patient prognosis
por: Toapanta, Néstor, et al.
Publicado: (2021)

Thiazide diuretics are back in CKD: the case of chlorthalidone
por: Minutolo, Roberto, et al.
Publicado: (2022)

The Latin American Dialysis and Renal Transplantation Registry: report 2019
por: Luxardo, Rosario, et al.
Publicado: (2021)

Bone mineral density and mortality in end-stage renal disease patients
por: Iseri, Ken, et al.
Publicado: (2020)

Potential hazards of recent trends in liberal iron use for renal anemia
por: Nakanishi, Takeshi, et al.
Publicado: (2020)

Challenges of defining renal response in ANCA-associated vasculitis: call to action?
por: Odler, Balazs, et al.
Publicado: (2023)

Intravenous fluid therapy in accordance with kidney injury risk: when to prescribe what volume of which solution
por: Kanbay, Mehmet, et al.
Publicado: (2022)

A new immune disease: systemic hypertension
por: Copur, Sidar, et al.
Publicado: (2023)

A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) Clinical Practice Guidelines on Acute Kidney Injury: Part 1: definitions, conservative management and contrast-induced nephropathy(†)
por: Fliser, Danilo, et al.
Publicado: (2012)

Sodium–glucose cotransporter 2 inhibitors: renal outcomes according to baseline albuminuria
por: Delanaye, Pierre, et al.
Publicado: (2021)

The effect of a ketogenic diet on weight loss in CKD: a randomized controlled trial in obese stage G1–3a CKD patients
por: Zoccali, Carmine, et al.
Publicado: (2023)

Late outcomes of renal denervation are more favourable than early ones: facts or fancies?
por: Persu, Alexandre, et al.
Publicado: (2023)

Practical approaches to building up a cardiorenal clinic
por: de la Espriella, Rafael, et al.
Publicado: (2022)

Novel strategies in nephrology: what to expect from the future?
por: Copur, Sidar, et al.
Publicado: (2022)

The emerging role of iron in heart failure and vascular calcification in CKD
por: Ciceri, Paola, et al.
Publicado: (2020)

An update review of intradialytic hypotension: concept, risk factors, clinical implications and management
por: Kanbay, Mehmet, et al.
Publicado: (2020)

A primer on metabolic memory: why existing diabesity treatments fail
por: Copur, Sidar, et al.
Publicado: (2020)

The long-term benefits of early intensive therapy in chronic diseases—the legacy effect
por: Zoccali, Carmine, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kcjsirdeq9jia4rrhh2tf2o6e5